首页 > 最新文献

Tzu Chi Medical Journal最新文献

英文 中文
Continuous positive airway pressure improved daytime sleepiness and memory function in patients with obstructive sleep apnea. 持续气道正压改善阻塞性睡眠呼吸暂停患者白天嗜睡和记忆功能。
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/tcmj.tcmj_4_22
Ya-Ling Hong, Yu-Chih Shen, En-Ting Chang, Shu-Chin Kung

Objectives: Obstructive sleep apnea (OSA) is a sleep disorder which results in daytime sleepiness and impaired memory function. The aim of this study was to investigate the effect of continuous positive airway pressure (CPAP) on daytime sleepiness and memory function in OSA patients. We also investigated whether CPAP compliance impacted the effect of this treatment.

Materials and methods: The nonrandomized, nonblinded clinical trial enrolled 66 patients with moderate-to-severe OSA subjects. All subjects completed a polysomnographic study, daytime sleepiness questionnaires (the Epworth Sleepiness Scale and the Pittsburgh Sleep Quality Index), and four memory function tests (working memory; processing speed [PS]; logical memory [LM]; face memory [FM]).

Results: Before CPAP treatment, no significant differences (P < 0.05) were noted in the demographic data, daytime sleepiness, or memory function between two groups (with/without CPAP). However, OSA patients treated with CPAP for 2 months showed significant improvements in daytime sleepiness, PS, mostly of LM, and FM comparing to 2 months ago. As compared to those who did not receive CPAP treatment, CPAP can improve only parts of LM (delayed LM [DLM] and LM percentage [LMP]). In addition, compared to control group, a significant improvement of daytime sleepiness and LM (LM learning, DLM, and LMP) in good compliance with CPAP treatment group and of DLM and LMP in the low compliance with CPAP treatment group was found.

Conclusion: CPAP treatment for 2 months could improve some of LM in OSA patients, especially in patients exhibiting good CPAP compliance.

目的:阻塞性睡眠呼吸暂停(OSA)是一种导致白天嗜睡和记忆功能受损的睡眠障碍。本研究旨在探讨持续气道正压通气(CPAP)对OSA患者日间嗜睡和记忆功能的影响。我们还调查了CPAP依从性是否会影响这种治疗的效果。材料与方法:非随机、非盲法临床试验纳入66例中重度OSA患者。所有受试者都完成了一项多导睡眠图研究,白天嗜睡问卷(Epworth嗜睡量表和匹兹堡睡眠质量指数),以及四项记忆功能测试(工作记忆;处理速度[PS];逻辑存储器;面部记忆[FM])。结果:CPAP治疗前,两组患者(加/不加CPAP治疗)在人口学数据、日间嗜睡、记忆功能方面均无显著差异(P < 0.05)。然而,与2个月前相比,接受CPAP治疗2个月的OSA患者在白天嗜睡、PS(主要是LM)和FM方面有显著改善。与未接受CPAP治疗的患者相比,CPAP仅能改善部分LM(延迟LM [DLM]和LM百分比[LMP])。此外,与对照组相比,良好依从性CPAP治疗组白天嗜睡和LM (LM学习、DLM和LMP)显著改善,低依从性CPAP治疗组DLM和LMP显著改善。结论:CPAP治疗2个月可以改善OSA患者的部分LM,特别是对CPAP依从性好的患者。
{"title":"Continuous positive airway pressure improved daytime sleepiness and memory function in patients with obstructive sleep apnea.","authors":"Ya-Ling Hong,&nbsp;Yu-Chih Shen,&nbsp;En-Ting Chang,&nbsp;Shu-Chin Kung","doi":"10.4103/tcmj.tcmj_4_22","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_4_22","url":null,"abstract":"<p><strong>Objectives: </strong>Obstructive sleep apnea (OSA) is a sleep disorder which results in daytime sleepiness and impaired memory function. The aim of this study was to investigate the effect of continuous positive airway pressure (CPAP) on daytime sleepiness and memory function in OSA patients. We also investigated whether CPAP compliance impacted the effect of this treatment.</p><p><strong>Materials and methods: </strong>The nonrandomized, nonblinded clinical trial enrolled 66 patients with moderate-to-severe OSA subjects. All subjects completed a polysomnographic study, daytime sleepiness questionnaires (the Epworth Sleepiness Scale and the Pittsburgh Sleep Quality Index), and four memory function tests (working memory; processing speed [PS]; logical memory [LM]; face memory [FM]).</p><p><strong>Results: </strong>Before CPAP treatment, no significant differences (<i>P</i> < 0.05) were noted in the demographic data, daytime sleepiness, or memory function between two groups (with/without CPAP). However, OSA patients treated with CPAP for 2 months showed significant improvements in daytime sleepiness, PS, mostly of LM, and FM comparing to 2 months ago. As compared to those who did not receive CPAP treatment, CPAP can improve only parts of LM (delayed LM [DLM] and LM percentage [LMP]). In addition, compared to control group, a significant improvement of daytime sleepiness and LM (LM learning, DLM, and LMP) in good compliance with CPAP treatment group and of DLM and LMP in the low compliance with CPAP treatment group was found.</p><p><strong>Conclusion: </strong>CPAP treatment for 2 months could improve some of LM in OSA patients, especially in patients exhibiting good CPAP compliance.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d7/81/TCMJ-35-84.PMC9972931.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9389134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experimental animal models and evaluation techniques in intracerebral hemorrhage. 脑出血实验动物模型及评价技术。
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/tcmj.tcmj_119_22
Shaik Ismail Mohammed Thangameeran, Cheng-Yoong Pang, Chien-Hui Lee, Sheng-Tzung Tsai, Wei-Fen Hu, Hock-Kean Liew

Intracerebral hemorrhage (ICH) is the most lethal type of cerebral stroke without effective therapy. Although clinical trials with various surgeries have been conducted, none have improved clinical outcomes compared to the current medical management for ICH. Several ICH animal models, including autologous blood injection, collagenase injection, thrombin injection, and microballoon inflation methods, have been developed to elucidate the underlying mechanisms of ICH-induced brain injury. These models could also be used for discovering new therapy for ICH preclinically. We summarize the existing ICH animal models and the evaluation parameters used to measure the disease outcomes. We conclude that these models, resembling the different aspects of ICH pathogenesis, have their advantages and disadvantages. None of the current models closely represent the severity of ICH seen in clinical settings. More appropriate models are needed to streamline ICH's clinical outcomes and be used for validating newly developed treatment protocols.

脑出血(ICH)是脑中风最致命的类型,没有有效的治疗。尽管已经进行了各种手术的临床试验,但与目前对脑出血的医疗管理相比,没有一种手术能改善临床结果。几种脑出血动物模型,包括自体血液注射、胶原酶注射、凝血酶注射和微球囊充气方法,已经被开发出来阐明脑出血诱导脑损伤的潜在机制。这些模型也可用于发现脑出血临床前治疗的新方法。我们总结了现有的ICH动物模型和用于衡量疾病结局的评价参数。我们的结论是,这些模型类似于脑出血发病的不同方面,有其优点和缺点。目前的模型都不能很好地代表临床环境中所见的脑出血的严重程度。需要更合适的模型来简化脑出血的临床结果,并用于验证新开发的治疗方案。
{"title":"Experimental animal models and evaluation techniques in intracerebral hemorrhage.","authors":"Shaik Ismail Mohammed Thangameeran,&nbsp;Cheng-Yoong Pang,&nbsp;Chien-Hui Lee,&nbsp;Sheng-Tzung Tsai,&nbsp;Wei-Fen Hu,&nbsp;Hock-Kean Liew","doi":"10.4103/tcmj.tcmj_119_22","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_119_22","url":null,"abstract":"<p><p>Intracerebral hemorrhage (ICH) is the most lethal type of cerebral stroke without effective therapy. Although clinical trials with various surgeries have been conducted, none have improved clinical outcomes compared to the current medical management for ICH. Several ICH animal models, including autologous blood injection, collagenase injection, thrombin injection, and microballoon inflation methods, have been developed to elucidate the underlying mechanisms of ICH-induced brain injury. These models could also be used for discovering new therapy for ICH preclinically. We summarize the existing ICH animal models and the evaluation parameters used to measure the disease outcomes. We conclude that these models, resembling the different aspects of ICH pathogenesis, have their advantages and disadvantages. None of the current models closely represent the severity of ICH seen in clinical settings. More appropriate models are needed to streamline ICH's clinical outcomes and be used for validating newly developed treatment protocols.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0c/7f/TCMJ-35-1.PMC9972928.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9389136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The relationship between child development and small for gestational age among preschool children. 学龄前儿童发育与胎龄小的关系。
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/tcmj.tcmj_227_21
Sheng-Hsun Chou, Shu-Hui Wen, Hsin-Chi Wu

Objectives: This study aimed to assess the impact of small for gestational age (SGA) on the development of Taiwanese preschool children using the Chinese Child Developmental Inventory (CCDI).

Materials and methods: A total of 982 children were enrolled in this study between June 2011 and December 2015. The samples were divided into two groups: SGA (n = 116, mean age = 2.98) and non-SGA (n = 866, mean age = 3.33) groups. The development scores were based on the CCDI, which consist of eight dimensions of development between the two groups. The linear regression analysis was adopted to examine the relationship of SGA with child development.

Results: On average, the children in the SGA group scored less in all eight subitems of the CCDI than those in the non-SGA group. However, regression analysis revealed that there was no significant difference in both performance and delay frequency in the CCDI between the two groups.

Conclusion: SGA children had similar developmental scores in CCDI as non-SGA children for preschool age in Taiwan.

摘要目的:本研究旨在利用中国儿童发展量表(CCDI)评估小胎龄(SGA)对台湾学龄前儿童发展的影响。材料与方法:2011年6月至2015年12月共纳入982名儿童。将样本分为SGA组(n = 116,平均年龄2.98)和非SGA组(n = 866,平均年龄3.33)。发展得分是基于CCDI,它由两组之间的八个发展维度组成。采用线性回归分析检验SGA与儿童发育的关系。结果:平均而言,SGA组儿童CCDI的8个分项得分均低于非SGA组。然而,回归分析显示,两组CCDI的性能和延迟频率均无显著差异。结论:台湾学龄前SGA儿童与非SGA儿童的CCDI发展得分相近。
{"title":"The relationship between child development and small for gestational age among preschool children.","authors":"Sheng-Hsun Chou,&nbsp;Shu-Hui Wen,&nbsp;Hsin-Chi Wu","doi":"10.4103/tcmj.tcmj_227_21","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_227_21","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to assess the impact of small for gestational age (SGA) on the development of Taiwanese preschool children using the Chinese Child Developmental Inventory (CCDI).</p><p><strong>Materials and methods: </strong>A total of 982 children were enrolled in this study between June 2011 and December 2015. The samples were divided into two groups: SGA (<i>n</i> = 116, mean age = 2.98) and non-SGA (<i>n</i> = 866, mean age = 3.33) groups. The development scores were based on the CCDI, which consist of eight dimensions of development between the two groups. The linear regression analysis was adopted to examine the relationship of SGA with child development.</p><p><strong>Results: </strong>On average, the children in the SGA group scored less in all eight subitems of the CCDI than those in the non-SGA group. However, regression analysis revealed that there was no significant difference in both performance and delay frequency in the CCDI between the two groups.</p><p><strong>Conclusion: </strong>SGA children had similar developmental scores in CCDI as non-SGA children for preschool age in Taiwan.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9e/27/TCMJ-35-78.PMC9972930.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10827920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between inhaled corticosteroid use and risk of hyperglycemia in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis 慢性阻塞性肺疾病患者吸入皮质类固醇使用与高血糖风险之间的关系:一项系统综述和荟萃分析
Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/tcmj.tcmj_131_23
Fathur Nur Kholis, Kevin Gracia Pratama, Jessica Novia Hadiyanto
A BSTRACT Objectives: Chronic obstructive pulmonary disease (COPD) patients have a higher risk of developing diabetes, and studies suggest that inhaled corticosteroids (ICSs) use may be associated with a higher risk of diabetes, particularly at higher doses. This study aims to investigate the effects of ICS use on the risk of diabetes and blood glucose levels in COPD patients. Materials and Methods: A systematic search was carried out on the PubMed, EBSCOhost, and ProQuest databases using the terms “Inhaled Corticosteroids,” “Diabetes,” and “Chronic Obstructive Pulmonary Disease” for the period between 2013 and 2023. The systematic review adhered to the PRISMA 2020 guideline. A meta-analysis was conducted using a random-effects model using the RevMan 5 software. Results: A total of 14 studies were included in the final analysis, with 10 randomized controlled trials (RCTs) and 4 observational studies. Two observational studies investigated the relationship between ICS dose and diabetes risk. A meta-analysis of the RCTs studies showed a nonstatistically significant tendency toward increased blood glucose (odds ratio [OR] 1.07 and 95% confidence interval [CI] 0.88–1.30) after a 52-week follow-up. Whereas the observational studies showed a tendency toward an increased risk of diabetes (OR 1.40 and 95% CI 0.96–2.03). Furthermore, a subgroup meta-analysis of high-dose ICS (>900 mg/day) showed a significant increase in the risk of diabetes (OR 1.20 and 95% CI 1.09–1.32). Conclusion: Short-term use of ICS does not have a significant effect on blood glucose. However, long-term use, especially at higher doses, can increase the risk of developing diabetes.
【摘要】目的:慢性阻塞性肺疾病(COPD)患者发生糖尿病的风险较高,研究表明,吸入性皮质类固醇(ICSs)的使用可能与糖尿病的高风险相关,特别是在高剂量时。本研究旨在探讨ICS使用对慢性阻塞性肺病患者糖尿病风险和血糖水平的影响。材料和方法:在PubMed、EBSCOhost和ProQuest数据库中系统检索2013年至2023年期间的“吸入皮质类固醇”、“糖尿病”和“慢性阻塞性肺疾病”。系统评价遵循PRISMA 2020指南。采用RevMan 5软件采用随机效应模型进行meta分析。结果:最终纳入14项研究,其中随机对照试验(rct) 10项,观察性研究4项。两项观察性研究调查了ICS剂量与糖尿病风险之间的关系。随机对照试验研究的荟萃分析显示,52周随访后血糖升高的趋势无统计学意义(优势比[OR] 1.07, 95%可信区间[CI] 0.88-1.30)。然而,观察性研究显示有增加糖尿病风险的趋势(OR 1.40, 95% CI 0.96-2.03)。此外,高剂量ICS (>900 mg/天)的亚组荟萃分析显示糖尿病风险显著增加(OR 1.20, 95% CI 1.09-1.32)。结论:短期使用ICS对血糖无明显影响。然而,长期使用,尤其是高剂量使用,会增加患糖尿病的风险。
{"title":"Association between inhaled corticosteroid use and risk of hyperglycemia in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis","authors":"Fathur Nur Kholis, Kevin Gracia Pratama, Jessica Novia Hadiyanto","doi":"10.4103/tcmj.tcmj_131_23","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_131_23","url":null,"abstract":"A BSTRACT Objectives: Chronic obstructive pulmonary disease (COPD) patients have a higher risk of developing diabetes, and studies suggest that inhaled corticosteroids (ICSs) use may be associated with a higher risk of diabetes, particularly at higher doses. This study aims to investigate the effects of ICS use on the risk of diabetes and blood glucose levels in COPD patients. Materials and Methods: A systematic search was carried out on the PubMed, EBSCOhost, and ProQuest databases using the terms “Inhaled Corticosteroids,” “Diabetes,” and “Chronic Obstructive Pulmonary Disease” for the period between 2013 and 2023. The systematic review adhered to the PRISMA 2020 guideline. A meta-analysis was conducted using a random-effects model using the RevMan 5 software. Results: A total of 14 studies were included in the final analysis, with 10 randomized controlled trials (RCTs) and 4 observational studies. Two observational studies investigated the relationship between ICS dose and diabetes risk. A meta-analysis of the RCTs studies showed a nonstatistically significant tendency toward increased blood glucose (odds ratio [OR] 1.07 and 95% confidence interval [CI] 0.88–1.30) after a 52-week follow-up. Whereas the observational studies showed a tendency toward an increased risk of diabetes (OR 1.40 and 95% CI 0.96–2.03). Furthermore, a subgroup meta-analysis of high-dose ICS (&gt;900 mg/day) showed a significant increase in the risk of diabetes (OR 1.20 and 95% CI 1.09–1.32). Conclusion: Short-term use of ICS does not have a significant effect on blood glucose. However, long-term use, especially at higher doses, can increase the risk of developing diabetes.","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136005095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Humoral immune response to an mRNA-1273 booster after chAdOx1-nCoV-19-priming among patients undergoing hemodialysis 血液透析患者在chadox1 - ncov -19启动后对mRNA-1273增强剂的体液免疫应答
Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/tcmj.tcmj_107_23
Bo-Yu Cheng, Ting-Yun Lin, Szu-Chun Hung
A BSTRACT Objectives: Patients who are undergoing dialysis due to end-stage kidney disease are susceptible to greater coronavirus disease 2019 (COVID-19) complications. While vaccination is seen as the most effective tactic against COVID-19, the dialysis population usually has impaired immune responses to vaccination. Owing to the global vaccine supply shortage in the early phase of the COVID-19 pandemic, hemodialysis patients in Taiwan were administered homologous ChAdOx1 nCoV-19/ChAdOx1 nCoV-19 at 12-week intervals, with a third booster shot of mRNA-1273 given 12 weeks after the second dose. We assessed the antibody responses of these patients to this extended-interval dosing protocol. Materials and Methods: A total of 168 hemodialysis patients (mean age: 67 ± 13 years) without prior COVID-19 infection were vaccinated between June 16, 2021, and January 5, 2022, and followed until February 10, 2022. The primary outcome was seroconversion with an antispike immunoglobulin G (IgG) antibody level ≥50 arbitrary units (AU)/mL at 4 weeks after the administration of an mRNA-1273 booster shot. The secondary outcome was the level of antispike IgG antibodies. Multivariable linear regression models were used to evaluate the associations between the baseline characteristics and the antispike IgG level. Results: A total of 163 (97.0%) patients reached the primary endpoint, with antibody levels after the third booster dose of mRNA-1273 being significantly higher than those after the second dose of ChAdOx1 nCoV-19 (median IgG titer 12,007 [4394–23,860] vs. 846 [interquartile range 295–2114] AU/mL; P < 0.001). Patients who were male, older, had a higher body mass index, had a lower total lymphocyte count, and used immunosuppressants had lower antibody levels. Conclusion: A third booster dose of mRNA-1273 after two consecutive priming doses of ChAdOx1 nCoV-19 with extended intervals resulted in adequate humoral immune responses among hemodialysis patients.
【摘要】目的:终末期肾病患者接受透析治疗时易发生冠状病毒病2019 (COVID-19)并发症。虽然疫苗接种被视为对抗COVID-19最有效的策略,但透析人群通常对疫苗接种的免疫反应受损。由于COVID-19大流行早期全球疫苗供应短缺,台湾血液透析患者每隔12周注射同源ChAdOx1 nCoV-19/ChAdOx1 nCoV-19,在第二次注射后12周注射第三次mRNA-1273加强针。我们评估了这些患者对延长间隔给药方案的抗体反应。材料与方法:于2021年6月16日至2022年1月5日期间,对168例既往无COVID-19感染的血液透析患者(平均年龄:67±13岁)接种疫苗,随访至2022年2月10日。主要终点是在注射mRNA-1273加强剂后4周抗刺突免疫球蛋白G (IgG)抗体水平≥50任意单位(AU)/mL的血清转化。次要指标为抗刺突IgG抗体水平。采用多变量线性回归模型评估基线特征与抗刺突IgG水平之间的关系。结果:共有163例(97.0%)患者达到主要终点,第三次mRNA-1273加强剂后的抗体水平显著高于第二次ChAdOx1 nCoV-19增强剂后的抗体水平(IgG滴度中位数12,007[4394-23,860]对846[四分位数范围295-2114]AU/mL;P & lt;0.001)。男性、年龄较大、身体质量指数较高、总淋巴细胞计数较低、使用免疫抑制剂的患者抗体水平较低。结论:在连续两次延长间隔的ChAdOx1 nCoV-19启动剂量后,第三次加强剂量mRNA-1273可在血液透析患者中产生足够的体液免疫反应。
{"title":"Humoral immune response to an mRNA-1273 booster after chAdOx1-nCoV-19-priming among patients undergoing hemodialysis","authors":"Bo-Yu Cheng, Ting-Yun Lin, Szu-Chun Hung","doi":"10.4103/tcmj.tcmj_107_23","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_107_23","url":null,"abstract":"A BSTRACT Objectives: Patients who are undergoing dialysis due to end-stage kidney disease are susceptible to greater coronavirus disease 2019 (COVID-19) complications. While vaccination is seen as the most effective tactic against COVID-19, the dialysis population usually has impaired immune responses to vaccination. Owing to the global vaccine supply shortage in the early phase of the COVID-19 pandemic, hemodialysis patients in Taiwan were administered homologous ChAdOx1 nCoV-19/ChAdOx1 nCoV-19 at 12-week intervals, with a third booster shot of mRNA-1273 given 12 weeks after the second dose. We assessed the antibody responses of these patients to this extended-interval dosing protocol. Materials and Methods: A total of 168 hemodialysis patients (mean age: 67 ± 13 years) without prior COVID-19 infection were vaccinated between June 16, 2021, and January 5, 2022, and followed until February 10, 2022. The primary outcome was seroconversion with an antispike immunoglobulin G (IgG) antibody level ≥50 arbitrary units (AU)/mL at 4 weeks after the administration of an mRNA-1273 booster shot. The secondary outcome was the level of antispike IgG antibodies. Multivariable linear regression models were used to evaluate the associations between the baseline characteristics and the antispike IgG level. Results: A total of 163 (97.0%) patients reached the primary endpoint, with antibody levels after the third booster dose of mRNA-1273 being significantly higher than those after the second dose of ChAdOx1 nCoV-19 (median IgG titer 12,007 [4394–23,860] vs. 846 [interquartile range 295–2114] AU/mL; P < 0.001). Patients who were male, older, had a higher body mass index, had a lower total lymphocyte count, and used immunosuppressants had lower antibody levels. Conclusion: A third booster dose of mRNA-1273 after two consecutive priming doses of ChAdOx1 nCoV-19 with extended intervals resulted in adequate humoral immune responses among hemodialysis patients.","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136004615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rodent models of senile normal-pressure hydrocephalus. 老年常压脑积水啮齿动物模型。
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/tcmj.tcmj_120_22
Li-Jin Chen, Sheng-Tzung Tsai, Guo-Fang Tseng

Cerebrospinal fluid (CSF) and its drainage are crucial in clearing metabolic waste and maintaining the microenvironment of the central nervous system for proper functioning. Normal-pressure hydrocephalus (NPH) is a serious neurological disorder of the elderly with obstruction of CSF flow outside the cerebral ventricles, causing ventriculomegaly. The stasis of CSF in NPH compromises brain functioning. Although treatable, often with shunt implantation for drainage, the outcome depends highly on early diagnosis, which, however, is challenging. The initial symptoms of NPH are hard to be aware of and the complete symptoms overlap with those of other neurological diseases. Ventriculomegaly is not specific to NPH as well. The lack of knowledge on the initial stages in its development and throughout its progression further deters early diagnosis. Thus, we are in dire need for an appropriate animal model for researches into a more thorough understanding of its development and pathophysiology so that we can enhance the diagnosis and therapeutic strategies to improve the prognosis of NPH following treatment. With this, we review the few currently available experimental rodent NPH models for these animals are smaller in sizes, easier in maintenance, and having a rapid life cycle. Among these, a parietal convexity subarachnoid space kaolin injection adult rat model appears promising as it shows a slow onset of ventriculomegaly in association with cognitive and motor disabilities resembling the elderly NPH in humans.

脑脊液(CSF)及其排泄对于清除代谢废物和维持中枢神经系统正常运作的微环境至关重要。常压脑积水(NPH)是一种严重的老年人神经系统疾病,脑室外脑脊液流动受阻,导致脑室肿大。脑脊液在NPH中的停滞会损害大脑功能。虽然可以治疗,通常通过分流管植入引流,但结果高度依赖于早期诊断,然而,这是具有挑战性的。NPH的初始症状难以察觉,其完整症状与其他神经系统疾病的症状重叠。脑室增大也不是NPH所特有的。缺乏对其发展的最初阶段和整个发展过程的了解进一步阻碍了早期诊断。因此,我们迫切需要一种合适的动物模型进行研究,以更深入地了解其发展和病理生理,从而提高诊断和治疗策略,改善NPH治疗后的预后。在此基础上,我们回顾了目前可用的几种实验性啮齿动物NPH模型,这些模型具有体积较小、易于维护和生命周期快的特点。其中,顶凸蛛网膜下腔高岭土注射成年大鼠模型看起来很有希望,因为它显示了与认知和运动障碍相关的脑室肿大的缓慢发作,类似于人类老年NPH。
{"title":"Rodent models of senile normal-pressure hydrocephalus.","authors":"Li-Jin Chen,&nbsp;Sheng-Tzung Tsai,&nbsp;Guo-Fang Tseng","doi":"10.4103/tcmj.tcmj_120_22","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_120_22","url":null,"abstract":"<p><p>Cerebrospinal fluid (CSF) and its drainage are crucial in clearing metabolic waste and maintaining the microenvironment of the central nervous system for proper functioning. Normal-pressure hydrocephalus (NPH) is a serious neurological disorder of the elderly with obstruction of CSF flow outside the cerebral ventricles, causing ventriculomegaly. The stasis of CSF in NPH compromises brain functioning. Although treatable, often with shunt implantation for drainage, the outcome depends highly on early diagnosis, which, however, is challenging. The initial symptoms of NPH are hard to be aware of and the complete symptoms overlap with those of other neurological diseases. Ventriculomegaly is not specific to NPH as well. The lack of knowledge on the initial stages in its development and throughout its progression further deters early diagnosis. Thus, we are in dire need for an appropriate animal model for researches into a more thorough understanding of its development and pathophysiology so that we can enhance the diagnosis and therapeutic strategies to improve the prognosis of NPH following treatment. With this, we review the few currently available experimental rodent NPH models for these animals are smaller in sizes, easier in maintenance, and having a rapid life cycle. Among these, a parietal convexity subarachnoid space kaolin injection adult rat model appears promising as it shows a slow onset of ventriculomegaly in association with cognitive and motor disabilities resembling the elderly NPH in humans.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/61/81/TCMJ-35-18.PMC9972929.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10827923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of cancer-associated mesenchymal stem cells in the tumor microenvironment: A review. 肿瘤相关间充质干细胞在肿瘤微环境中的作用综述
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/tcmj.tcmj_138_22
Kai-Hung Wang, Dah-Ching Ding

Mesenchymal stem cells (MSCs) were applied to the therapy for degenerative diseases, immune, and inflammation. In tumor microenvironments (TME), different sources of MSCs showed that tumor-promoting and -inhibiting effects were mediated by different signaling pathways. Cancer-associated MSCs (CaMSCs) could be recruited from bone marrow or local tissues and mainly showed tumor-promoting and immunosuppressive effects. The transformed CaMSCs preserve the characteristics of stem cells, but the properties of regulating TME are different. Hence, we specifically focus on CaMSCs and discuss the detailed mechanisms of regulating the development of cancer cells and immune cells. CaMSCs could be a potential therapeutic target in various types of cancer. However, the detailed mechanisms of CaMSCs in the TME are relatively less known and need further study.

间充质干细胞(MSCs)应用于退行性疾病、免疫和炎症的治疗。在肿瘤微环境(TME)中,不同来源的MSCs显示出不同的信号通路介导的促肿瘤和抑制作用。肿瘤相关间充质干细胞(CaMSCs)可以从骨髓或局部组织中募集,主要表现为促肿瘤和免疫抑制作用。转化后的CaMSCs保留了干细胞的特征,但调节TME的特性不同。因此,我们特别关注CaMSCs,并讨论了调节癌细胞和免疫细胞发育的详细机制。CaMSCs可能是多种类型癌症的潜在治疗靶点。然而,CaMSCs在TME中的具体机制尚不清楚,需要进一步研究。
{"title":"Role of cancer-associated mesenchymal stem cells in the tumor microenvironment: A review.","authors":"Kai-Hung Wang,&nbsp;Dah-Ching Ding","doi":"10.4103/tcmj.tcmj_138_22","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_138_22","url":null,"abstract":"<p><p>Mesenchymal stem cells (MSCs) were applied to the therapy for degenerative diseases, immune, and inflammation. In tumor microenvironments (TME), different sources of MSCs showed that tumor-promoting and -inhibiting effects were mediated by different signaling pathways. Cancer-associated MSCs (CaMSCs) could be recruited from bone marrow or local tissues and mainly showed tumor-promoting and immunosuppressive effects. The transformed CaMSCs preserve the characteristics of stem cells, but the properties of regulating TME are different. Hence, we specifically focus on CaMSCs and discuss the detailed mechanisms of regulating the development of cancer cells and immune cells. CaMSCs could be a potential therapeutic target in various types of cancer. However, the detailed mechanisms of CaMSCs in the TME are relatively less known and need further study.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f6/8f/TCMJ-35-24.PMC9972927.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9389132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Status of resource recycling stations in Taiwan and recycling work-related health effects. 台湾资源回收站现状及回收工作对健康的影响。
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/tcmj.tcmj_111_22
Chung-Shan Hung, Lih-Ming Yiin, Chia-Feng Yen, Chia-Jung Hsieh, Jyh-Gang Hsieh, Chun-Chieh Tseng

Resource recycling has become an integral part of environmental protection efforts. At present, the development of Taiwan's resource recovery and related works are quite mature. However, laborers or volunteers working in resource recycling stations may be exposed to different types of hazards during the recycling process. These hazards can be divided into biological, chemical, and musculoskeletal problems. These hazards are usually related to the work environment and work habits; therefore, a related control strategy is needed. Tzu Chi's recycling business has been running for over 30 years. In addition to leading the trend of resource recycling in Taiwan, many elderly people have also participated in Tzu Chi recycling stations as volunteers. These older volunteers may be more sensitive to exposure to hazards, and thus the focus of this review is to illustrate the possible hazards and health impacts of resource recovery work and to recommend relevant interventions to improve occupational health during resource recovery work.

资源循环利用已成为环境保护的重要组成部分。目前,台湾的资源回收及相关工作的发展已经相当成熟。然而,在资源回收站工作的劳动者或志愿者在回收过程中可能会接触到不同类型的危害。这些危害可分为生物、化学和肌肉骨骼问题。这些危害通常与工作环境和工作习惯有关;因此,需要一种相关的控制策略。慈济的回收事业已经经营了30多年。除了引领台湾资源回收的潮流外,许多老人也以义工的身份参与慈济回收站。这些年龄较大的志愿者可能对危害暴露更敏感,因此本综述的重点是说明资源回收工作可能存在的危害和健康影响,并建议相关干预措施,以改善资源回收工作期间的职业健康。
{"title":"Status of resource recycling stations in Taiwan and recycling work-related health effects.","authors":"Chung-Shan Hung,&nbsp;Lih-Ming Yiin,&nbsp;Chia-Feng Yen,&nbsp;Chia-Jung Hsieh,&nbsp;Jyh-Gang Hsieh,&nbsp;Chun-Chieh Tseng","doi":"10.4103/tcmj.tcmj_111_22","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_111_22","url":null,"abstract":"<p><p>Resource recycling has become an integral part of environmental protection efforts. At present, the development of Taiwan's resource recovery and related works are quite mature. However, laborers or volunteers working in resource recycling stations may be exposed to different types of hazards during the recycling process. These hazards can be divided into biological, chemical, and musculoskeletal problems. These hazards are usually related to the work environment and work habits; therefore, a related control strategy is needed. Tzu Chi's recycling business has been running for over 30 years. In addition to leading the trend of resource recycling in Taiwan, many elderly people have also participated in Tzu Chi recycling stations as volunteers. These older volunteers may be more sensitive to exposure to hazards, and thus the focus of this review is to illustrate the possible hazards and health impacts of resource recovery work and to recommend relevant interventions to improve occupational health during resource recovery work.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/66/40/TCMJ-35-38.PMC9972934.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10827925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitamin K and vascular calcification in chronic kidney disease: An update of current evidence. 慢性肾脏疾病的维生素K和血管钙化:最新证据
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-01-01 DOI: 10.4103/tcmj.tcmj_100_22
Yu-Li Lin, Bang-Gee Hsu

Vascular calcification, characterized by calcium deposition in the intimal and medial layers of the arterial wall, is frequently encountered in patients with chronic kidney disease (CKD) and leads to an enhanced risk of adverse cardiovascular (CV) outcomes. However, the underlying complex pathophysiology remains incompletely understood. Recently, Vitamin K supplementation aimed at correcting Vitamin K deficiency highly prevalent in CKD holds great promise to mitigate the progression of vascular calcification. This article discusses the functional Vitamin K status in CKD, the pathophysiology linking Vitamin K deficiency and vascular calcification, and reviews current literature from animal models, observational studies, and clinical trials across the different spectrum of CKD. While favorable effects of Vitamin K on vascular calcification and CV outcomes are suggested in animal and observational studies, most recently published clinical trials investigating the effects of Vitamin K on vascular health failed to support the beneficial role of Vitamin K supplementation, despite improving the functional status of Vitamin K. We address the potential reasons for these discrepancies and provide further perspective on Vitamin K research in CKD.

血管钙化以动脉壁内膜和内层钙沉积为特征,常见于慢性肾脏疾病(CKD)患者,并导致心血管(CV)不良结局的风险增加。然而,潜在的复杂病理生理机制仍不完全清楚。最近,维生素K补充剂旨在纠正CKD中普遍存在的维生素K缺乏症,有望缓解血管钙化的进展。本文讨论了CKD中维生素K的功能状态,维生素K缺乏与血管钙化之间的病理生理学联系,并回顾了目前来自动物模型、观察性研究和不同CKD临床试验的文献。虽然动物和观察性研究表明维生素K对血管钙化和心血管结果有有利作用,但最近发表的研究维生素K对血管健康影响的临床试验未能支持补充维生素K的有益作用,尽管它改善了维生素K的功能状态。我们解决了这些差异的潜在原因,并为维生素K在CKD中的研究提供了进一步的视角。
{"title":"Vitamin K and vascular calcification in chronic kidney disease: An update of current evidence.","authors":"Yu-Li Lin,&nbsp;Bang-Gee Hsu","doi":"10.4103/tcmj.tcmj_100_22","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_100_22","url":null,"abstract":"<p><p>Vascular calcification, characterized by calcium deposition in the intimal and medial layers of the arterial wall, is frequently encountered in patients with chronic kidney disease (CKD) and leads to an enhanced risk of adverse cardiovascular (CV) outcomes. However, the underlying complex pathophysiology remains incompletely understood. Recently, Vitamin K supplementation aimed at correcting Vitamin K deficiency highly prevalent in CKD holds great promise to mitigate the progression of vascular calcification. This article discusses the functional Vitamin K status in CKD, the pathophysiology linking Vitamin K deficiency and vascular calcification, and reviews current literature from animal models, observational studies, and clinical trials across the different spectrum of CKD. While favorable effects of Vitamin K on vascular calcification and CV outcomes are suggested in animal and observational studies, most recently published clinical trials investigating the effects of Vitamin K on vascular health failed to support the beneficial role of Vitamin K supplementation, despite improving the functional status of Vitamin K. We address the potential reasons for these discrepancies and provide further perspective on Vitamin K research in CKD.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/36/2a/TCMJ-35-44.PMC9972925.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9389131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Editorial comment on Vitamin K and vascular calcification in chronic kidney disease: An update of current evidence - The role of Vitamin K in managing chronic kidney disease-mineral bone disorder. 慢性肾病中维生素K和血管钙化的社论评论:当前证据的更新-维生素K在治疗慢性肾病-矿物质骨紊乱中的作用。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-01-01 DOI: 10.4103/tcmj.tcmj_206_22
Yi-Chou Hou, Kuo-Cheng Lu
{"title":"Editorial comment on Vitamin K and vascular calcification in chronic kidney disease: An update of current evidence - The role of Vitamin K in managing chronic kidney disease-mineral bone disorder.","authors":"Yi-Chou Hou,&nbsp;Kuo-Cheng Lu","doi":"10.4103/tcmj.tcmj_206_22","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_206_22","url":null,"abstract":"","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/35/b0/TCMJ-35-51.PMC9972935.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10827922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Tzu Chi Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1